Argyropoulos, S. V., Sandford, J. J. & Nutt, D. J. (2000) The psychobiology of anxiolytic drugs. Part 2: Pharmacological treatments of anxiety. Pharmacology and Therapeutics, 88, 213–227.
Ballenger, J. C. (1993) Panic disorder: efficacy of current treatments. Psychopharmacology Bulletin, 29, 477–486.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2001) British National Formulary (September issue). London & Wallingford: BMJ Books and Pharmaceutical Press.
Brooner, R. K., King, V. L., Kidorf, M.
et al (1997) Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71–80.
Brown, S. A., Irwin, M. & Schuckit, M. A. (1991) Changes in anxiety among abstinent male alcoholics. Journal of Studies on Alcohol, 52, 55–61.
Carlson, J. G., Chemtob, C. M., Rusnak, K.
et al (1998) Eye movement desensitization and reprocessing [EMDR] treatment for combat-related posttraumatic stress disorder. Journal of Traumatic Stress, 11, 3–24.
Ciraulo, A. D. & Nace, E. P. (2000) Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. American Journal of Addiction, 9, 276–284.
Cloninger, C. R., Bohman, M. & Sigvardsson, S. (1981) Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Archives of General Psychiatry, 38(8), 861–868.
Coplan, J. D., Liebowitz, M. R., Gorman, J. M.
et al (1992) Noradrenergic function in panic disorder. Effects of intravenous clonidine pre-treatment on lactate induced panic. Biological Psychiatry, 31, 135–146.
Davidson, J. R., Potts, N., Richichi, E.
et al (1993) Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology, 13(6), 423–428.
Devilly, G. J. & Spence, S. H. (1999) The relative efficacy and treatment distress of EMDR and a cognitive behavioural treatment protocol in the amelioration of post traumatic stress disorder. Journal of Anxiety Disorders, 13, 131–157.
George, D. T., Zerby, A., Noble, S.
et al (1988) Panic attacks and alcohol withdrawal: can subjects differentiate the symptoms?
Biological Psychiatry, 24, 240–243.
George, D. T., Nutt, D. J., Dwyer, B. A.
et al (1990) Alcoholism and panic disorder: is the comorbidity more than coincindence?
Acta Psychiatrica Scandinavica, 81, 97–107.
George, D. T., Benkelfat, C., Rawlings, R. R.
et al (1997) Behavioural and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. American Journal of Psychiatry, 154, 81–87.
Heinz, A., Mann, K., Weinberger, D. R.
et al (2001) Serotonergic dysfunction, negative mood states, and response to alcohol. Alcoholism, Clinical and Experimental Research, 25, 487–495.
Himle, J. A., Abelson, J. L., Haghightgou, H.
et al (1999) Effect of alcohol on social phobic anxiety. American Journal of Psychiatry, 156, 1237–1243.
Keaney, K., Strang, J., Gossop, M.
et al (2001) A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide. Alcohol and Alcoholism, 36, 426–430.
Kessler, R. C., McGonagle, K. A., Zhao, S.
et al (1994) Lifetime and 12-month prevalence of DSM–III–R psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8–19.
Kessler, R. C., Crum, R. M., Warner, L. A.
et al (1997) Lifetime cooccurrence of DSM–III–R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54, 313–321.
Kranzler, H. R., Burleson, J. A., Del Boca, F. K.
et al (1994) Buspirone treatment of anxious alcoholics. Archives of General Psychiatry, 51, 720–734.
Kranzler, H. R., Burleson, J. A., Brown, J.
et al (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive–behavioural therapy in type B alcoholics. Alcoholism, Clinical and Experimental Research, 20, 1534–1541.
Krausz, M., Degkwitz, P., Kühne, A.
et al (1998) Comorbidity of opiate dependence and mental disorders. Addictive Behaviors, 23, 767–783.
Kushner, M. G., Sher, K. J. & Beitman, B.D. (1990) The relation between alcohol problems and anxiety disorders. American Journal of Psychiatry, 147, 685–695.
Lesch, O. & Walter, H. (1996) Subtypes of alcoholism and their role in therapy. Alcohol and Alcoholism, 31 (suppl. 1), 63–67.
Lingford-Hughes, A. R., Acton, P. D., Gacinovic, S.
et al (1998) Reduced levels of the GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. British Journal of Psychiatry, 173, 116–122.
Malizia, A. L., Cunningham, V. J., Bell, C. J.
et al (1998) Decreased brain GABA A-benzodiazepine receptor binding in panic disorder. Archives of General Psychiatry, 55, 715–720.
Merikangas, K. R., Mehta, R. L., Molnar, B. E.
et al (1998) Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addictive Behaviors, 23, 893–907.
Nutt, D. J. (1999) Alcohol and the brain. Pharmacological insights for psychiatrists. British Journal of Psychiatry, 175, 114–119.
Nutt, D. J. & Cowen, P. J. (1987) Diazepam alters brain 5HT function in man: implications for the acute and chronic effects of benzodiazepines. Psychological Medicine, 17, 601–607.
Pitman, R. K., Orr, S. P., Altman, B.
et al (1996) Emotional processing during eye movement desensitization and reprocessing [EMDR] therapy of Vietnam veterans with post-traumatic stress disorder. Comprehensive Psychiatry, 37, 419–429.
Potokar, J., Coupland, N., Wilson, S.
et al (1999) Assessment of GABA A benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology, 146, 180–184.
Quitkin, F. M., Rifkin, A., Kaplan, J.
et al (1972) Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse. Archives of General Psychiatry, 27, 159–162.
Raistrick, D. (2000) Management of alcohol detoxification. Advances in Psychiatric Treatment, 6, 348–355.
Randall, C. L., Thomas, S. E. & Thevos, A. K. (2000) Gender comparison in alcoholics with concurrent social phobia: implications for alcoholism treatment. American Journal of Addiction, 9, 202–215.
Randall, C. L., Thomas, S. E. & Thevos, A. K. (2001) Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcoholism, Clinical and Experimental Research, 25, 210–220.
Regier, D. A., Farmer, M. E., Rae, D. S.
et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. JAMA, 264, 2511–2518.
Rothbaum, B. O. (1997) A controlled study of eye movement desensitization and reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bulletin of the Menninger Clinic, 61(3), 317–334.
Roy-Byrne, P. P., Lewis, N., Villacres, E.
et al (1989) Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biological Psychiatry, 26, 744–748.
Rudolph, U., Crestani, F. & Mohler, H. (2001) GABAA receptor subtypes: dissecting out their pharmacological functions. Trends in Pharmacological Sciences, 22, 188–194.
Saunders, J. B., Aasland, O. G., Babor, T. F.
et al (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption – II. Addiction, 88, 791–804.
Schneier, F. R., Goetz, D., Campeas, R.
et al (1998) Placebo-controlled trial of moclobemide in social phobia. British Journal of Psychiatry, 172, 70–77.
Scott, J., Gilvarry, E. & Farrell, M. (1998) Managing anxiety and depression in alcohol and drug dependence. Addictive Behaviors, 23, 919–931.
Nardi, A. E., Mundim, F. D.
et al (1992) Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. British Journal of Psychiatry, 161, 353–360.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders. Geneva: WHO.